Search clinical trials for: Systemic treatment Stereotactic Body Radio-Therapy (SBRT)

Total 934 results

Peking University Third Hospital

Recruiting

Safety and Efficacy of SBRT in the Reirradiation for Ultra-central Thoracic Malignant Tumors

Recurrent Cancer | Stereotactic Body Radiation Therapy | Thoracic Tumor | Irradiation; Reaction

China
Haihua Yang

Unknown

Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Early Stereotactic Body Radiation Therapy to the Primary Tumor in Advanced Non-small Cell Lung Cancer

Advanced Non-small Cell Lung Cancer

China
NYU Langone Health
AstraZeneca

Withdrawn

Study of Immune Checkpoint Inhibition With Radiation Therapy in Unresectable, Non-metastatic Pancreatic Cancer

Pancreatic Cancer

United States
Canadian Cancer Trials Group
Canadian Cancer Society (CCS)

Recruiting

Local Ablative Therapy For Hormone Sensitive Oligometastatic Prostate Cancer (PLATON)

Prostate Cancer Metastatic

Canada
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Withdrawn

MRI-Guided Radiation Therapy for the Treatment of Early-Stage Kidney Cancer, the MRI-MARK Trial

Renal Cell Carcinoma | Stage I Renal Cell Cancer AJCC v8 | Stage II Renal Cell Cancer AJCC v8

United States
Emory University

Completed

Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer

Pancreas Cancer | Pancreas Neoplasms | Cancer of Pancreas | Cancer of the Pancreas | Neoplasms, Pancreatic

United States
Jinling Hospital, China

Recruiting

A Study of Multimodal Radiotherapy for Renal Cell Carcinoma Progressed After Prior Immunotherapy

Renal Cell Carcinoma | Radiotherapy | Immune Checkpoint Inhibitor

China
University of Oxford
University of Leeds; Centre for Statistics in Medicine; Oncology Clinical Trials... and other collaborators

Completed

SBRT Pre-operatively for Pancreatic Cancer (SPARC)

Pancreatic Neoplasms

United Kingdom
University of Michigan Rogel Cancer Center

Completed

Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for High Risk Prostate Cancer

Prostate Cancer

United States
Immodulon Therapeutics Ltd

Completed

A Study of IMM-101 in Combination With Radiation Induced Tumour Necrosis in Colorectal Cancer

Metastatic Colorectal Cancer

United Kingdom
National Cancer Institute (NCI)

Recruiting

Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor

Prostatic Neoplasms | Prostate Cancer | Prostate Adenocarcinoma

United States
Grupo de Investigación Clínica en Oncología Radioterapia

Completed

Phase II Study of SBRT as Treatment for Oligometastases in Prostate Cancer

Oligometastatic Prostate Cancer

Spain
Icahn School of Medicine at Mount Sinai

Active, not recruiting

Rectal Spacer Hydrogel Before Radiation Therapy in Reducing Radiation Dose to the Rectum in Patients With Prostate Cancer

Prostate Cancer

United States
Hangzhou Cancer Hospital

Unknown

SBRT Combined With Thymalfasin for Metastatic Esophageal Cancer

Esophageal Cancer | Stereotactic Body Radiation Therapy | Metastatic Esophageal Cancer | Thymalfasin

China
University of Colorado, Denver
AstraZeneca

Withdrawn

Immunotherapy Combined With Y-90 and SBRT for Colorectal Liver Metastases

Colorectal Cancer
University of Rochester
Varian Medical Systems

Recruiting

This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surgery for Cancer, and Then Have Evidence That Their Prostate Cancer Has Returned. (DASBRT-RPC)

Recurrent Prostate Cancer After Surgery

United States
Lawson Health Research Institute

Active, not recruiting

A Phase II Trial Measuring the Integration of Stereotactic Radiotherapy Plus Surgery in Early Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer

Canada
Third Military Medical University

Completed

Prospective Study of Stereotactic Body Radiation Therapy for Thymoma Inoma: Therapeutic Effect and Toxicity Assessment

Thymoma | Thymic Tumor

China
Universitair Ziekenhuis Brussel

Unknown

Non-interventional Observational Study of Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Cancer

Neoplasm Metastasis

Belgium
H. Lee Moffitt Cancer Center and Research Institute
Bristol-Myers Squibb

Active, not recruiting

Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma

Skin Cancer | Merkel Cell Carcinoma

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of Head and Neck

Squamous Cell Carcinoma of the Head and Neck

United States
Washington University School of Medicine
Varian Medical Systems

Recruiting

Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer

Prostate Cancer | Cancer of the Prostate

United States
Jonsson Comprehensive Cancer Center

Active, not recruiting

Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer

Stage III Prostate Cancer | Adenocarcinoma of the Prostate

United States
Jonsson Comprehensive Cancer Center
POINT Biopharma

Active, not recruiting

177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Oligorecurrent Prostate Cancer, The LUNAR Study (LUNAR)

Prostate Adenocarcinoma | Stage IVB Prostate Cancer AJCC v8 | Oligometastatic Prostate Carcinoma | Recurrent Prostate Adenocarcinoma

United States
Second Affiliated Hospital, School of Medicine,...

Not yet recruiting

Adjuvant Stereotactic Body Radiotherapy (SBRT) for Hepatocellular Carcinoma After Hepatectomy With Narrow Margin: a Prospective, Multi-center, Randomized Controlled, Open-labelled, Phase III Study

Hepatocellular Carcinoma | Hepatectomy | Narrow Margin | Adjuvant Stereotactic Body Radiotherapy

China
National Cancer Institute (NCI)

Active, not recruiting

Testing the Addition of Radiation Therapy to Immunotherapy for Merkel Cell Carcinoma

Advanced Merkel Cell Carcinoma | Metastatic Merkel Cell Carcinoma | Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8 | Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8 | Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8 | Pathologic Stage IIIA Cutaneous Merkel... and other conditions

United States
Changhai Hospital

Recruiting

Integrated Boost to the Dominant Intraprostatic Nodule Based on Ga-68 PSMA PET/MR Study of SBRT With Prostate Cancer (SBRT)

Treatment

China
Washington University School of Medicine
National Cancer Institute (NCI); Verastem, Inc.

Recruiting

Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma

Pancreas Adenocarcinoma | Pancreas Cancer | Cancer of the Pancreas

United States
Shanghai Chest Hospital

Unknown

Phase II Trial of SBRT Compared With Conventional Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer

NSCLC

China
Weill Medical College of Cornell University
Convergent Therapeutics, Inc.

Withdrawn

ACTInium-J591 Radionuclide Therapy in PSMA-Detected Metastatic HOrmone-Sensitive Recurrent Prostate CaNcer (ACTION)

Prostate Cancer Metastatic

United States
Memorial Sloan Kettering Cancer Center

Completed

Screening Trial of Nivolumab With Image Guided, Stereotactic Body Radiotherapy (SBRT) Versus Nivolumab Alone in Patients With Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

Head and Neck Squamous Cell Carcinoma (HNSCC)

United States
Abramson Cancer Center at Penn Medicine
Oregon Health and Science University; Loyola University

Active, not recruiting

TACE With or Without SBRT as Bridging Therapy for Pre-transplant HCC Patients

Hepatocellular Carcinoma

United States
M.D. Anderson Cancer Center

Terminated

Metformin in Non Small Cell Lung Cancer (NSCLC)

Lung Cancer

United States
Stanford University

Terminated

Combination SBRT With TACE for Unresectable Hepatocellular Carcinoma

Carcinoma, Hepatocellular | Hepatobiliary Neoplasm | Liver Carcinoma

United States
University of Kansas Medical Center
Varian Medical Systems

Recruiting

vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC (vGRID SBRT)

Liver Cancer

United States
Sun Yat-sen University

Completed

RFA Versus SBRT for Recurrent Small HCC

Hepatocellular Carcinoma

China
UNICANCER

Recruiting

Prostate-cancer Treatment Using Stereotactic Radiotherapy for Oligometastases Ablation in Hormone-sensitive Patients (Oligo-PRESTO)

Oligometastatic Hormone Sensitive Prostate Cancer

France, Martinique
Brown University
Lifespan

Active, not recruiting

Durvalumab and Consolidation SBRT Following Chemoradiation for Locally Advanced Stage III Non-Small Cell Lung (358)

Stage III Non-small-cell Lung Cancer

United States
Royal North Shore Hospital

Terminated

Idronoxil Suppository Combine With Radiotherapy for Metastatic Prostate Cancer

Metastatic Castrate- Resistant Prostate Cancer

Australia
Megan Daly, MD
Genentech, Inc.

Active, not recruiting

Atezolizumab and Stereotactic Body Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

Stage I Non-Small Cell Lung Cancer

United States
University of Cincinnati

Terminated

Safety Study of SBRT and Docetaxel for Locally Recurrent or Second Primary Squamous Cell Carcinoma of the Head and Neck

Head and Neck Cancer

United States
M.D. Anderson Cancer Center
Bristol-Myers Squibb

Completed

Ipilimumab and Stereotactic Body Radiation Therapy (SBRT) in Advanced Solid Tumors

Lung Cancer | Liver Cancer

United States
M.D. Anderson Cancer Center
Varian Medical Systems

Completed

Lung Cancer STARS Trial - STARS Revised Clinical Trial Protocol: Stereotactic Ablative Radiotherapy (SABR) in Stage I Non-small Cell Lung Cancer Patients Who Can Undergo Lobectomy

Lung Cancer

United States
West China Hospital

Recruiting

Combination of Sintilimab and Stereotactic Body Radiotherapy in Advanced Metastatic HCC

Immunotherapy | SBRT | Stage IV HCC

China
European Organisation for Research and Treatment...

Completed

Synergism of Immunomodulation and Tumor Ablation (ILOC)

Colorectal Cancer | Liver Metastases

France, Netherlands, Switzerland, Germany, Austria, Sweden
Indiana University

Terminated

Y90 Radiation Segmentectomy vs SBRT for HCC (SBRT vs Y90)

Hepatocellular Carcinoma (HCC)

United States
Riverside Community Hospital, California

Unknown

CyberKnife Stereotactic Radiosurgery for Low and Intermediate Risk Prostate Cancer

Prostate Cancer

United States
Stanford University
National Cancer Institute (NCI)

Terminated

Transarterial Chemoembolization Compared With Stereotactic Body Radiation Therapy or Stereotactic Ablative Radiation Therapy in Treating Patients With Residual or Recurrent Liver Cancer Undergone Initial Transarterial Chemoembolization

Recurrent Hepatocellular Carcinoma | Child-Pugh Class A | Child-Pugh Class B

United States, Japan
ETOP IBCSG Partners Foundation
AstraZeneca

Active, not recruiting

Osimertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR Mutant NSCLC (STEREO) (STEREO)

NSCLC Stage IV | EGFR Gene Mutation

Singapore, Sweden, Korea, Republic of, Spain, Switzerland, Netherlands, Italy, Poland
Yale University

Completed

Evaluating the Combination of MK-3475 and Sterotactic Body Radiotherapy in Patients With Metastatic Melanoma or NSCLC

Melanoma | Lung Cancer

United States

Search clinical trials for: Systemic treatment Stereotactic Body Radio-Therapy (SBRT)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Montenegro

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations